Data and statistics support for liver cancer (HCC) research

Biostatistics and Bioinformatics Core (BBC)

NIH-funded research Virginia Commonwealth University · NIH-11159552

Helping researchers use data and statistics to find better treatment combinations for people with liver cancer, especially when linked to NASH.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University NIH-funded
Lab location1 site (Richmond, United States)
Project IDNIH-11159552 on NIH RePORTER

What this research studies

This core provides expert biostatistics and bioinformatics help to the ELEVATE team working on hepatocellular carcinoma (HCC), with special attention to NASH-related HCC. It helps plan experiments, decide how many samples or animals are needed, and set up analyses so results are reliable. The team also manages research data and works with projects that use mouse models and other preclinical tools to test new drug combinations. By improving study design and data handling, the core aims to make the lab and translational work more likely to produce clear answers.

Who could benefit from this research

Good fit: People with hepatocellular carcinoma, especially those whose cancer is linked to NASH, could be candidates for future clinical trials that arise from this work.

Not a fit: Individuals without liver cancer or with cancers unrelated to HCC/NASH are unlikely to directly benefit from this specific project.

Why it matters

Potential benefit: If successful, this support could speed development of safer and more effective treatment combinations for people with HCC, particularly NASH-related cases.

How similar studies have performed: Some targeted and immunotherapy approaches have helped subsets of liver cancer patients, but combining treatments for NASH-related HCC remains an emerging area with limited prior success.

Where this research is happening

Richmond, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer Biology
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.